Literature DB >> 25760567

Pharyngeal colonization by Streptococcus pneumoniae in older children and adolescents in a geographical area characterized by relatively limited pneumococcal vaccination coverage.

Nicola Principi1, Leonardo Terranova, Alberto Zampiero, Valentina Montinaro, Valentina Ierardi, Walter Peves Rios, Claudio Pelucchi, Susanna Esposito.   

Abstract

BACKGROUND: The aim of this study was to evaluate the relation between colonization and vaccination status with pneumococcal conjugate vaccine (PCV) in older children and adolescents living in an area characterized by relatively limited vaccination coverage.
METHODS: Oropharyngeal swabs were obtained from 2076 randomly selected healthy school-age children and adolescents, and the extracted genomic DNA was tested for Streptococcus pneumoniae by means of real-time polymerase chain reaction. All of the positive cases were subsequently serotyped, and the association between vaccination status with the heptavalent PCV (PCV7) and pneumococcal colonization was determined.
RESULTS: S. pneumoniae was identified in the oropharyngeal swabs of 1201 subjects (57.9%), and its prevalence declined with age (74.9% in subjects aged <10 years, 51.8% in those aged 10-14 years and 32.7% in those aged ≥15 years; P < 0.001). There were more carriers of any pneumococcal serotype, any of the serotypes in PCV7, or any of the 6 additional serotypes in 13-valent PCV (PCV13) among the vaccinated than the unvaccinated subjects, but no association emerged after adjustment for age and other selected covariates. Sub-analyses by serotype and age groups revealed significant differences in the case of serotypes 3 and 19A among children aged <10 years (odds ratios of 2.03 and 2.18, respectively).
CONCLUSIONS: These results show the absence of any long-term effect of PCV7 on colonization, and raise doubts concerning the recent suggestion to use carriage to evaluate the efficacy of PCVs. The high prevalence of carriers in all of the age groups independent of previous pneumococcal vaccination indicates that further studies are needed to evaluate whether the extensive use of PCVs in healthy older children and adolescents might reduce pharyngeal colonization of these subjects thereby increasing herd immunity.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25760567     DOI: 10.1097/INF.0000000000000637

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  8 in total

1.  Serological criteria and carriage measurement for evaluation of new pneumococcal vaccines.

Authors:  Nicola Principi; Susanna Esposito
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

2.  Streptococcus pneumoniae oropharyngeal colonization in school-age children and adolescents with type 1 diabetes mellitus: Impact of the heptavalent pneumococcal conjugate vaccine.

Authors:  Nicola Principi; Lorenzo Iughetti; Marco Cappa; Claudio Maffeis; Franco Chiarelli; Gianni Bona; Monia Gambino; Luca Ruggiero; Viviana Patianna; Maria Cristina Matteoli; Marco Marigliano; Paola Cipriano; Silvia Parlamento; Susanna Esposito
Journal:  Hum Vaccin Immunother       Date:  2015-11-17       Impact factor: 3.452

3.  Streptococcus pneumoniae pharyngeal colonization in school-age children and adolescents with cancer.

Authors:  Nicola Principi; Valentina Preti; Stefania Gaspari; Antonella Colombini; Marco Zecca; Leonardo Terranova; Maria Giuseppina Cefalo; Valentina Ierardi; Claudio Pelucchi; Susanna Esposito
Journal:  Hum Vaccin Immunother       Date:  2016       Impact factor: 3.452

4.  Pneumococcal colonization in older adults.

Authors:  Susanna Esposito; Daniela Mari; Luigi Bergamaschini; Annalisa Orenti; Leonardo Terranova; Luca Ruggiero; Valentina Ierardi; Monia Gambino; Francesco Della Croce; Nicola Principi
Journal:  Immun Ageing       Date:  2016-01-12       Impact factor: 6.400

5.  Streptococcus pneumoniae colonisation in children and adolescents with asthma: impact of the heptavalent pneumococcal conjugate vaccine and evaluation of potential effect of thirteen-valent pneumococcal conjugate vaccine.

Authors:  Susanna Esposito; Leonardo Terranova; Maria Francesca Patria; Gian Luigi Marseglia; Michele Miraglia del Giudice; Alessandro Bodini; Alberto Martelli; Eugenio Baraldi; Oscar Mazzina; Claudia Tagliabue; Amelia Licari; Valentina Ierardi; Mara Lelii; Nicola Principi
Journal:  BMC Infect Dis       Date:  2016-01-12       Impact factor: 3.090

6.  Pneumococcal Colonization in the Familial Context and Implications for Anti-Pneumococcal Immunization in Adults: Results from the BINOCOLO Project in Sicily.

Authors:  Fabio Tramuto; Emanuele Amodio; Giuseppe Calamusa; Vincenzo Restivo; Claudio Costantino; Francesco Vitale
Journal:  Int J Mol Sci       Date:  2017-01-06       Impact factor: 5.923

7.  Distribution of serotypes and patterns of antimicrobial resistance among commensal Streptococcus pneumoniae in nine European countries.

Authors:  Rachid Y Yahiaoui; Hester J Bootsma; Casper D J den Heijer; Gerlinde N Pluister; W John Paget; Peter Spreeuwenberg; Krzysztof Trzcinski; Ellen E Stobberingh
Journal:  BMC Infect Dis       Date:  2018-08-29       Impact factor: 3.090

8.  Molecular surveillance of nasopharyngeal carriage of Streptococcus pneumoniae in children vaccinated with conjugated polysaccharide pneumococcal vaccines.

Authors:  Anne L Wyllie; Alienke J Wijmenga-Monsuur; Marlies A van Houten; Astrid A T M Bosch; James A Groot; Jody van Engelsdorp Gastelaars; Jacob P Bruin; Debby Bogaert; Nynke Y Rots; Elisabeth A M Sanders; Krzysztof Trzciński
Journal:  Sci Rep       Date:  2016-04-05       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.